Electra Therapeutics Inc. (ETRA) vs RxSight, Inc. (RXST)

A side-by-side comparison of Electra Therapeutics Inc. and RxSight, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ETRA

Electra Therapeutics Inc.

$207M

$9.74HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

RXST

RxSight, Inc.

$192M

$4.64HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — ETRA vs RXST

growth of $100 · dividends reinvested · last 1y

ETRA -26.5% (-26.5%/yr)RXST -10.5% (-10.5%/yr)RXST compounded faster over this window

ETRA RXST

Metrics side by side

Total return (annualized)

Metric	ETRA	RXST
Total return (1Y)	N/A	-45.75%
Total return CAGR (3Y)	N/A	-43.37%
Total return CAGR (5Y)	N/A	-19.19%

ETRA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ETRA analysis Full RXST analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.